RxDoctor Payments Data

Christopher Dunn, MD

Family Medicine · Estero, FLNPI 1205944220

Payments from drug & device makers

$845in general payments, 2019–2025

Across 69 payments — averaging $12.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • Penumbra, Inc.$131
  • Amarin Pharma, Inc.$46
  • Esperion Therapeutics, Inc.$18
  • Biohaven Pharmaceutical Holding Company Ltd.$17
  • Lilly USA, LLC$16
  • plus $54 from 4 others

What the payments were for

  • Food & beverage$845100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$845 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$123,566
Medicare patients
517
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$24,899
EliquisApixaban16$22,184
MounjaroTirzepatide15$18,976
Celecoxib25$2,592
Atorvastatin Calcium171$1,584
Pantoprazole Sodium106$1,372
Rosuvastatin Calcium103$1,314
Tamsulosin Hcl76$1,286
Solifenacin Succinate14$1,107
Nebivolol Hcl17$1,015
Escitalopram Oxalate58$980
Gabapentin53$902
Levothyroxine Sodium123$896
Omeprazole64$810
Ezetimibe34$743

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$24,89917 claims
Lilly USA, LLCMounjaro$16$18,97615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Estero

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →